{"ORPHApacket":[{"ORPHApacketID":"639","date":"2019-12-06 08:02:27","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"639","Name":[{"lang":"en","label":"Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_639","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Rare neuroinflammatory or neuroimmunological disease"}],"ORPHA":"182064","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_182064"},{"Name":[{"lang":"en","label":"Chronic acquired demyelinating polyneuropathy"}],"ORPHA":"208974","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_208974"},{"Name":[{"lang":"en","label":"Peripheral neuropathy associated with monoclonal gammopathy"}],"ORPHA":"209010","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_209010"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Polyneuropathy associated with IgM monoclonal gammapathy (MG) with anti-MAG (myelin-associated-glycoprotein) activity is a demyelinating polyneuropathy characterized clinically by sensory ataxia, tremor, paresthesia, and impaired gait."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Adult"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Unknown"}]}]}],"SynonymList":[{"count":"2","Synonym":[{"lang":"en","label":"Anti-MAG neuropathy"},{"lang":"en","label":"Neuropathy associated with monoclonal IgM antibodies to myelin-associated glycoprotein"}]}],"HPODisorderAssociationList":[{"count":"9","HPODisorderAssociation":[{"HPOId":"HP:0002166","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002166","HPOTerm":"Impaired vibration sensation in the lower limbs","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0007133","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0007133","HPOTerm":"Progressive peripheral neuropathy","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0011402","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0011402","HPOTerm":"Demyelinating sensory neuropathy","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002936","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002936","HPOTerm":"Distal sensory impairment","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0003693","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0003693","HPOTerm":"Distal amyotrophy","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0005508","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0005508","HPOTerm":"Monoclonal immunoglobulin M proteinemia","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0007220","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0007220","HPOTerm":"Demyelinating motor neuropathy","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0100287","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0100287","HPOTerm":"EMG: slow motor conduction","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0006865","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0006865","HPOTerm":"Sensorimotor polyneuropathy affecting arms more than legs","HPOFrequency":[{"ORPHA":"453315","Name":[{"lang":"en","label":"Excluded (0%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}